The Pharma Data

JANUARY 12, 2021

The data could help doctors diagnose and treat athletes recovering from COVID-19 who have developed myocarditis, an inflammation of the heart. TUESDAY, Jan. Guidelines include cardiac testing for those who had COVID-19 symptoms. She is on the steering committee for the registry.

Cardiology 52

Cardiology Medicine Doctor Doctors 52

FDA Law Blog

FEBRUARY 21, 2022

Unger, who is a 1971 recipient of the Rensselaer Polytechnic Institute Mathematics and Science Medal, earned a Bachelor of Science (magna cum laude) in chemistry from Wright State University in Dayton, Ohio, and a Doctor of Medicine from the University of Cincinnati College of Medicine in Cincinnati, Ohio.

Drugs 40

Drugs Cardiology FDA Approval Doctor 40

The Pharma Data

DECEMBER 16, 2020

But while the reasons for the disparity are not nailed down, doctors need to be aware of it, Kapadia said. In general, he said, women who develop cardiovascular complications during or after pregnancy have warning signs prior. Women with those conditions need to see their doctor regularly after giving birth, according to Kapadia.

Doctor 52

Doctor Doctors Cardiology Medicine 52

The Pharma Data

NOVEMBER 4, 2020

However, while telemedicine seemed to make it easy to check in with a primary care doctor, a new study suggests that wasn’t the case for everyone. ” Diabetes, hypertension and heart disease are common chronic diseases that require a lot of management by doctors, Virani noted. WEDNESDAY, Nov.

Doctors 52

Doctors Doctor Medicine Cardiology 52

Velocity Clinical Research

DECEMBER 6, 2023

In addition to being one of Poland’s top recruiting sites in cardiology trials, ClinMedica also recruits patients across a broad range of therapeutic areas involving ambulatory medicine. About Grzegorz Kania, MD Grzegorz Kania, MD specializes in cardiology as well as internal and family medicine. and Europe.

Clinical Research 52

Clinical Research Research Clinical Trials Clinical Trials 52

The Pharma Data

NOVEMBER 4, 2020

If your doctor decided that urgent treatment with ULTOMIRIS is needed, you should receive meningococcal vaccination as soon as possible. Your doctor will decide if you need additional vaccination. Your doctor will give you a Patient Safety Card about the risk of meningococcal infection.

Doctors 52

Doctors Doctor Vaccine Vaccination 52

The Pharma Data

NOVEMBER 16, 2020

It would be easier for patients, who wouldn’t have to juggle fistfuls of daily medications, and for doctors who’d only have to write one prescription. of those who took aspirin alone developed heart-related illness, compared to 4.7% Salim Yusuf, a professor of medicine at McMaster University in Canada. who took the placebo.

Doctor 52

Doctor Doctors Cardiology Medicine 52

The Pharma Data

JULY 8, 2021

vice president, Clinical Development & Medical Affairs, Cardio-Metabolism & Respiratory Medicine, Boehringer Ingelheim Pharmaceuticals, Inc. vice president, Product Development, Lilly. vice president, Product Development, Lilly. ” The EMPEROR-Preserved trial investigated Jardiance 10 mg compared with placebo. .”

Trials 52

Trials Doctors Doctor Medicine 52

Velocity Clinical Research

JANUARY 3, 2024

In my new role as Vice President Corporate Development (CEE) and Medical Director (CEE) together with my expertise of building out a site network, I intend to support the development of Velocity in Poland and in Europe more widely.” About Marek Konieczny, MD, PhD Dr. Konieczny is a specialist in cardiology and internal medicine.

Clinical Trials 52

Clinical Trials Clinical Trials Clinical Research Trials 52

The Pharma Data

JANUARY 26, 2021

He holds an honorary Doctor of Science from Purdue University and has been named a distinguished alumnus of both Purdue and Washington University. Serota earned a bachelor’s degree from Purdue University and a master’s degree in health administration and planning from the Washington University School of Medicine. About Itamar Medical Ltd.

Cardiology 40

Cardiology Doctor Doctors Marketing 40

The Pharma Data

JANUARY 5, 2021

5, 2021 — Kids born with heart defects may be more likely to develop anxiety , depression and/or attention-deficit/hyperactivity disorder (ADHD), regardless of the severity of their heart condition. These children often miss school and social activities due to doctors’ visits or health restrictions. . TUESDAY, Jan.

Cardiology 52

Cardiology Doctor Doctors Genetics 52

The Pharma Data

JANUARY 21, 2021

21, 2021 – – With rising obesity rates, more young women American women are developing type 2 diabetes , putting them at hugely increased risk for heart disease, new research shows. 20 in the journal JAMA Cardiology. 20 in the journal JAMA Cardiology. THURSDAY, Jan. ” Mora agreed. © 2021 HealthDay. .”

Insulin 52

Insulin Cardiology Research Doctor 52

Pharma Marketing Network

FEBRUARY 27, 2025

Pharma brands can develop: Whitepapers on clinical trials showcasing drug effectiveness. Scientific blogs discussing new advancements in oncology, cardiology, or rare diseases. Doctor-patient interviews on managing chronic conditions. Behind-the-scenes research lab videos showcasing drug development.

Branding 52

Branding Marketing Compliance Pharma Companies 52

pharmaphorum

AUGUST 3, 2021

The FDA has approved an artificial intelligence-based imaging software developed by Abbott that is used to help physicians carry out procedures like implanting stents to open up narrowed blood vessels in the heart. . It allows stents to be placed faster and with more precision, helping doctors provide the best care for patients, he added.

Doctor 52

Doctor Doctors Development Cardiology 52

The Pharma Data

JANUARY 27, 2021

Adding a chapter on pregnancy complications puts that issue “front and center,” said Dr. Salim Virani, chair of the report’s writing committee and a professor of cardiology and cardiovascular research at Baylor College of Medicine in Houston. Overall, 10% to 20% of women will have some kind of health issue during pregnancy.

Medicine 52

Medicine Cardiology Doctor Doctors 52

The Pharma Data

NOVEMBER 4, 2020

Expanded m edical society recommendations in support of the efficacy and safety of VASCEPA : The European Society of Cardiology expanded their guidelines to recommend use of VASCEPA in treating acute coronary syndrome patients. Research and development (R&D) expense for the three and nine months ended September 30, 2020 were $10.2

Sales 40

Sales Production Marketing Cardiology 40